Recipharm signs partnership agreement on pharmaceutical development with Follicum
Recipharm has today announced that it has signed a partnership agreement with Follicum AB in preparation for a clinical trial of the drug candidate FOL-005.Recipharm has been engaged to formulate and produce the product that will be used in the clinical trial. The engagement also includes developing and validating the analytical methods required. “Preparations for the clinical study are well under way, and we have now established ties with partners that we feel confident in. Recipharm is successful in its field and has a strong track record. We look forward to the finished product, which